Tvardi Therapeutics, Inc. (TVRD) NASDAQ
Currency In USD
AD
- General
- Statistics
- Historical Data
- Profile
- Financials
AD
Currency In USD
| Market Cap | 31.9M |
| Enterprise Value | 11.37M |
| P/E Ratio | -1.95 |
| PEG Ratio | -0.01 |
| Price/Sales Ratio | 0 |
| Price/Book Ratio | 2 |
| Enterprise/Revenue | 0 |
| Enterprise/EBITDA | -0.61 |
| Fiscal Year | December 31, 2025 |
| Most Recent Quarter | March 31, 2026 |
| Profit Margin | 0 |
| Operating Margin | 0 |
| Return On Assets | -0.6 |
| Return On Equity | -0.64 |
| Revenue | 0 |
| Revenue/Share | 0 |
| Gross Profit | -95,000 |
| EBITDA | -18.12M |
| Net Income | -18.21M |
| Diluted EPS | -3.26 |
| Total Cash | 24.98M |
| Total Cash/Share | 2.66 |
| Total Debt | 174,000 |
| Total Debt/Equity | 0.01 |
| Current Ratio | 2.25 |
| Book Value Per Share | 1.55 |
| 52-Week Change | -85.59 |
| 52-Week High | 43.65 |
| 52-Week Low | 1.5 |
| Moving Average 50 Days | 3.08 |
| Moving Average 200 Days | 6.77 |
| Average Volume | 1.3M |
| Shares Outstanding | 9.38M |
| % Held by Institutions | 36.44 |
| Trailing Annual Dividend Rate | 0 |
| Trailing Annual Dividend Yield | 0 |
| Payout Ratio | 0 |
| Last Split Factor | N/A |
| Last Split Date | N/A |